Acute Modification of Hemodynamic Forces in Patients with Severe Aortic Stenosis after Transcatheter Aortic Valve Implantation.
Alessandro VairoLorenzo ZaccaroAndrea BallatoreLorenzo AiraleFabrizio D'AscenzoGianluca AlunniFederico ConrottoLuca ScudelerDaniela MascarettiDavide MiccoliMichele La TorreMauro RinaldiGianni PedrizzettiStefano SalizzoniGaetano Maria De FerrariPublished in: Journal of clinical medicine (2023)
Transcatheter aortic valve implantation (TAVI) is the established first-line treatment for patient with severe aortic stenosis not suitable for surgery. Echocardiographic evaluation of hemodynamic forces (HDFs) is a growing field, holding the potential to early predict improvement in LV function. A prospective observational study was conducted. Transthoracic echocardiography was performed before and after TAVI. HDFs were analyzed along with traditional left ventricular (LV) function parameters. Twenty-five consecutive patients undergoing TAVI were enrolled: mean age 83 ± 5 years, 74.5% male, mean LV Ejection Fraction (LVEF) at baseline 57 ± 8%. Post-TAVI echocardiographic evaluation was performed 2.4 ± 1.06 days after the procedure. HDF amplitude parameters improved significantly after the procedure: LV Longitudinal Forces (LF) apex-base [mean difference (MD) 1.79%; 95% CI 1.07-2.5; p -value < 0.001]; LV systolic LF apex-base (MD 2.6%; 95% CI 1.57-3.7; p -value < 0.001); LV impulse (LVim) apex-base (MD 2.9%; 95% CI 1.48-4.3; p -value < 0.001). Similarly, HDFs orientation parameters improved: LVLF angle (MD 1.5°; 95% CI 0.07-2.9; p -value = 0.041); LVim angle (MD 2.16°; 95% CI 0.76-3.56; p -value = 0.004). Conversely, global longitudinal strain and LVEF did not show any significant difference before and after the procedure. Echocardiographic analysis of HDFs could help differentiate patients with LV function recovery after TAVI from patients with persistent hemodynamic dysfunction.
Keyphrases
- aortic stenosis
- transcatheter aortic valve implantation
- left ventricular
- ejection fraction
- aortic valve replacement
- minimally invasive
- transcatheter aortic valve replacement
- molecular dynamics
- heart failure
- left atrial
- hypertrophic cardiomyopathy
- aortic valve
- cardiac resynchronization therapy
- mitral valve
- acute myocardial infarction
- patients undergoing
- blood pressure
- liver failure
- high resolution
- drug induced
- case report
- hepatitis b virus
- coronary artery bypass
- risk assessment
- respiratory failure